蓝鲨加速器vp-快连加速器app

蓝鲨加速器vp-快连加速器app

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

蓝鲨加速器vp-快连加速器app

Learn More
Folded page of a newspaper

蓝鲨加速器vp-快连加速器app

蓝鲨加速器vp-快连加速器app

Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results

蓝鲨加速器vp-快连加速器app

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

蓝鲨加速器vp-快连加速器app

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

蓝鲨加速器vp-快连加速器app

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

蓝鲨加速器vp-快连加速器app

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

蓝鲨加速器vp-快连加速器app

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

抖音国际版加速器  不用实名认证登录的加速器  手机vp哪个好  PVN加速器，国外  佛挑墙pc版  极光加速npv官网网址  极光vln